NPPB and heart failure: In the 2014, the pro-BNP outpatient chronic heart failure therapy (PROTECT) study by Gaggin et al. evaluated the ability of sST2 to identify the risk of left ventricular remodeling in outpatients with low ejection fraction heart failure.